Comparison of whole genome amplification and nested-PCR methods for preimplantation genetic diagnosis for BRCA1 gene mutation on unfertilized oocytes–a pilot study

[1]  Pgd,et al.  Preimplantation genetic diagnosis. , 2019, Fertility and sterility.

[2]  Danuta Januszkiewicz-Lewandowska,et al.  Prevalence of the most frequent BRCA1 mutations in Polish population , 2011, Journal of Applied Genetics.

[3]  Lindsey M. King,et al.  Conflict between values and technology: perceptions of preimplantation genetic diagnosis among women at increased risk for hereditary breast and ovarian cancer , 2009, Familial Cancer.

[4]  M. Werner,et al.  Preimplantation genetic diagnosis for BRCA1/2—a novel clinical experience , 2009, Prenatal diagnosis.

[5]  N. Muntjewerff,et al.  ESHRE PGD Consortium data collection V: cycles from January to December 2002 with pregnancy follow-up to October 2003. , 2008, Human reproduction.

[6]  I. Jacobs,et al.  Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer. , 2007, Human reproduction.

[7]  A. Nowicki,et al.  [Self-examination influence on breast cancer detection. Research conducted in women after breast amputation]. , 2007, Ginekologia polska.

[8]  S. Gayther,et al.  Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention , 2006, Acta obstetricia et gynecologica Scandinavica.

[9]  A. Jakubowska,et al.  A high proportion of founder BRCA1 mutations in Polish breast cancer families , 2004, International journal of cancer.

[10]  J. Hopper,et al.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.

[11]  Å. Borg,et al.  BRCA1 and BRCA2 mutation analysis in breast‐ovarian cancer families from northeastern Poland , 2003, Human mutation.

[12]  B. Ponder,et al.  The genetics of ovarian cancer. , 2002, Best practice & research. Clinical obstetrics & gynaecology.

[13]  A. Jakubowska,et al.  Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. , 2000, American journal of human genetics.

[14]  J. Ranstam,et al.  Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  P. Hartge,et al.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.

[16]  B. Ponder,et al.  Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. , 1997, American journal of human genetics.

[17]  M. Morgan,et al.  Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. , 1996, The New England journal of medicine.

[18]  A. H. Handyside,et al.  Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification , 1990, Nature.

[19]  C. Moutou,et al.  ESHRE PGD Consortium data collection IV: May-December 2001. , 2005, Human reproduction.

[20]  T. Pieńkowski,et al.  The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer and the frequency of occurrence of these tumours in their relatives. , 2004, European journal of gynaecological oncology.

[21]  A. Jakubowska,et al.  Molecular basis of inherited predispositions for tumors. , 2002, Acta biochimica Polonica.

[22]  E. Grzybowska,et al.  Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population. , 2002, Acta biochimica Polonica.